776 related articles for article (PubMed ID: 30582455)
1. Hippo Deficiency Leads to Cardiac Dysfunction Accompanied by Cardiomyocyte Dedifferentiation During Pressure Overload.
Ikeda S; Mizushima W; Sciarretta S; Abdellatif M; Zhai P; Mukai R; Fefelova N; Oka SI; Nakamura M; Del Re DP; Farrance I; Park JY; Tian B; Xie LH; Kumar M; Hsu CP; Sadayappan S; Shimokawa H; Lim DS; Sadoshima J
Circ Res; 2019 Jan; 124(2):292-305. PubMed ID: 30582455
[TBL] [Abstract][Full Text] [Related]
2. gp130 Controls Cardiomyocyte Proliferation and Heart Regeneration.
Li Y; Feng J; Song S; Li H; Yang H; Zhou B; Li Y; Yue Z; Lian H; Liu L; Hu S; Nie Y
Circulation; 2020 Sep; 142(10):967-982. PubMed ID: 32600062
[TBL] [Abstract][Full Text] [Related]
3. Yes-associated protein (YAP) mediates adaptive cardiac hypertrophy in response to pressure overload.
Byun J; Del Re DP; Zhai P; Ikeda S; Shirakabe A; Mizushima W; Miyamoto S; Brown JH; Sadoshima J
J Biol Chem; 2019 Mar; 294(10):3603-3617. PubMed ID: 30635403
[TBL] [Abstract][Full Text] [Related]
4. Yes-Associated Protein (YAP) Facilitates Pressure Overload-Induced Dysfunction in the Diabetic Heart.
Ikeda S; Mukai R; Mizushima W; Zhai P; Oka SI; Nakamura M; Del Re DP; Sciarretta S; Hsu CP; Shimokawa H; Sadoshima J
JACC Basic Transl Sci; 2019 Sep; 4(5):611-622. PubMed ID: 31768477
[TBL] [Abstract][Full Text] [Related]
5. miR-206 Mediates YAP-Induced Cardiac Hypertrophy and Survival.
Yang Y; Del Re DP; Nakano N; Sciarretta S; Zhai P; Park J; Sayed D; Shirakabe A; Matsushima S; Park Y; Tian B; Abdellatif M; Sadoshima J
Circ Res; 2015 Oct; 117(10):891-904. PubMed ID: 26333362
[TBL] [Abstract][Full Text] [Related]
6. Neddylation mediates ventricular chamber maturation through repression of Hippo signaling.
Zou J; Ma W; Li J; Littlejohn R; Zhou H; Kim IM; Fulton DJR; Chen W; Weintraub NL; Zhou J; Su H
Proc Natl Acad Sci U S A; 2018 Apr; 115(17):E4101-E4110. PubMed ID: 29632206
[TBL] [Abstract][Full Text] [Related]
7. Acetylation of VGLL4 Regulates Hippo-YAP Signaling and Postnatal Cardiac Growth.
Lin Z; Guo H; Cao Y; Zohrabian S; Zhou P; Ma Q; VanDusen N; Guo Y; Zhang J; Stevens SM; Liang F; Quan Q; van Gorp PR; Li A; Dos Remedios C; He A; Bezzerides VJ; Pu WT
Dev Cell; 2016 Nov; 39(4):466-479. PubMed ID: 27720608
[TBL] [Abstract][Full Text] [Related]
8. Dystrophin-glycoprotein complex sequesters Yap to inhibit cardiomyocyte proliferation.
Morikawa Y; Heallen T; Leach J; Xiao Y; Martin JF
Nature; 2017 Jul; 547(7662):227-231. PubMed ID: 28581498
[TBL] [Abstract][Full Text] [Related]
9. NF2 Activates Hippo Signaling and Promotes Ischemia/Reperfusion Injury in the Heart.
Matsuda T; Zhai P; Sciarretta S; Zhang Y; Jeong JI; Ikeda S; Park J; Hsu CP; Tian B; Pan D; Sadoshima J; Del Re DP
Circ Res; 2016 Aug; 119(5):596-606. PubMed ID: 27402866
[TBL] [Abstract][Full Text] [Related]
10. Hippo pathway effector Yap promotes cardiac regeneration.
Xin M; Kim Y; Sutherland LB; Murakami M; Qi X; McAnally J; Porrello ER; Mahmoud AI; Tan W; Shelton JM; Richardson JA; Sadek HA; Bassel-Duby R; Olson EN
Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13839-44. PubMed ID: 23918388
[TBL] [Abstract][Full Text] [Related]
11. Alpha-catenins control cardiomyocyte proliferation by regulating Yap activity.
Li J; Gao E; Vite A; Yi R; Gomez L; Goossens S; van Roy F; Radice GL
Circ Res; 2015 Jan; 116(1):70-9. PubMed ID: 25305307
[TBL] [Abstract][Full Text] [Related]
12. Lats2 promotes heart failure by stimulating p53-mediated apoptosis during pressure overload.
Shao D; Zhai P; Hu C; Mukai R; Sciarretta S; Del Re D; Sadoshima J
Sci Rep; 2021 Dec; 11(1):23469. PubMed ID: 34873220
[TBL] [Abstract][Full Text] [Related]
13. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction.
Abe I; Terabayashi T; Hanada K; Kondo H; Teshima Y; Ishii Y; Miyoshi M; Kira S; Saito S; Tsuchimochi H; Shirai M; Yufu K; Arakane M; Daa T; Thumkeo D; Narumiya S; Takahashi N; Ishizaki T
Cardiovasc Res; 2021 Mar; 117(4):1103-1117. PubMed ID: 32647865
[TBL] [Abstract][Full Text] [Related]
14. Upstream regulation of the Hippo-Yap pathway in cardiomyocyte regeneration.
Flinn MA; Link BA; O'Meara CC
Semin Cell Dev Biol; 2020 Apr; 100():11-19. PubMed ID: 31606277
[TBL] [Abstract][Full Text] [Related]
15. The Hippo pathway in the heart: pivotal roles in development, disease, and regeneration.
Wang J; Liu S; Heallen T; Martin JF
Nat Rev Cardiol; 2018 Nov; 15(11):672-684. PubMed ID: 30111784
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Myocardial Cell Growth and Death by the Hippo Pathway.
Ikeda S; Sadoshima J
Circ J; 2016 Jun; 80(7):1511-9. PubMed ID: 27302848
[TBL] [Abstract][Full Text] [Related]
17. Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size.
Xin M; Kim Y; Sutherland LB; Qi X; McAnally J; Schwartz RJ; Richardson JA; Bassel-Duby R; Olson EN
Sci Signal; 2011 Oct; 4(196):ra70. PubMed ID: 22028467
[TBL] [Abstract][Full Text] [Related]
18. Intercalated disc protein Xinβ is required for Hippo-YAP signaling in the heart.
Guo H; Lu YW; Lin Z; Huang ZP; Liu J; Wang Y; Seok HY; Hu X; Ma Q; Li K; Kyselovic J; Wang Q; Lin JL; Lin JJ; Cowan DB; Naya F; Chen Y; Pu WT; Wang DZ
Nat Commun; 2020 Sep; 11(1):4666. PubMed ID: 32938943
[TBL] [Abstract][Full Text] [Related]
19. Melatonin promotes cardiomyocyte proliferation and heart repair in mice with myocardial infarction via miR-143-3p/Yap/Ctnnd1 signaling pathway.
Ma WY; Song RJ; Xu BB; Xu Y; Wang XX; Sun HY; Li SN; Liu SZ; Yu MX; Yang F; Ye DY; Gong R; Han ZB; Yu Y; Bamba D; Wang N; Pan ZW; Cai BZ
Acta Pharmacol Sin; 2021 Jun; 42(6):921-931. PubMed ID: 32839503
[TBL] [Abstract][Full Text] [Related]
20. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size.
Heallen T; Zhang M; Wang J; Bonilla-Claudio M; Klysik E; Johnson RL; Martin JF
Science; 2011 Apr; 332(6028):458-61. PubMed ID: 21512031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
